Indian firm Global Pharma Healthcare's Artificial Tears eye drops product, which led to three deaths and blinded some patients in the US, did not test positive for contamination during Indian tests, according to India's health ministry sources. The US Food and Drug Administration had ordered recall of the product in February, and the US Centers for Disease Control and Prevention had identified "a rare strain of extensively drug-resistant" bacteria linked to the drops.
